| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 94,479 | |||
| Restricted cash | 113 | |||
| Trade and other receivables | 7 | |||
| Prepaid and other assets | 480 | |||
| Total current assets | 95,079 | |||
| Total property and equipment, gross | 1,601 | |||
| Accumulated depreciation and amortization | 1,483 | |||
| Property and equipment, net | 118 | |||
| Deposits | 55 | |||
| Prepaid and other assets | 20 | |||
| Right-of-use assets | 755 | |||
| Total assets | 96,027 | |||
| Trade and other payables | 1,148 | |||
| Accrued employee benefits | 463 | |||
| Lease liabilities, current portion | 414 | |||
| Total current liabilities | 2,025 | |||
| Lease liabilities, less current portion | 403 | |||
| Total liabilities | 2,428 | |||
| Common stock, 0.0001 par value160,000,000 shares authorized 26,250,469 shares issued and outstanding at september30, 2025 and june30, 2025, respectively | 2 | |||
| Additional paid-in capital | 331,488 | |||
| Accumulated deficit | -237,141 | |||
| Accumulated other comprehensive loss | -750 | |||
| Total stockholders' equity | 93,599 | |||
| Total liabilities and stockholders' equity | 96,027 | |||
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)